Sweet KL - Search Results

1

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes.

Sallman DA, DeZern AE, Garcia-Manero G, Steensma DP, Roboz GJ, Sekeres MA, Cluzeau T, Sweet KL, McLemore A, McGraw KL, Puskas J, Zhang L, Yao J, Mo Q, Nardelli L, Al Ali NH, Padron E, Korbel G, Attar EC, Kantarjian HM, Lancet JE, Fenaux P, List AF, Komrokji RS. Sallman DA, et al. Among authors: sweet kl. J Clin Oncol. 2021 May 10;39(14):1584-1594. doi: 10.1200/JCO.20.02341. Epub 2021 Jan 15. J Clin Oncol. 2021. PMID: 33449813 Free PMC article. Clinical Trial.

2

Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison.

Phillips KM, Pinilla-Ibarz J, Sotomayor E, Lee MR, Jim HS, Small BJ, Sokol L, Lancet J, Tinsley S, Sweet K, Komrokji R, Jacobsen PB. Phillips KM, et al. Support Care Cancer. 2013 Apr;21(4):1097-103. doi: 10.1007/s00520-012-1630-5. Epub 2012 Nov 20. Support Care Cancer. 2013. PMID: 23179489

3

Biomarkers for determining the prognosis in chronic myelogenous leukemia.

Sweet K, Zhang L, Pinilla-Ibarz J. Sweet K, et al. J Hematol Oncol. 2013 Jul 19;6:54. doi: 10.1186/1756-8722-6-54. J Hematol Oncol. 2013. PMID: 23870290 Free PMC article. Review.

4

Novel therapeutics in acute myeloid leukemia.

Sweet K, Lancet JE. Sweet K, et al. Curr Hematol Malig Rep. 2014 Jun;9(2):109-17. doi: 10.1007/s11899-014-0199-0. Curr Hematol Malig Rep. 2014. PMID: 24633743 Review.

5

Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerations.

Sweet K, Pinilla-Ibarz J, Zhang L. Sweet K, et al. Patient Prefer Adherence. 2014 Jul 8;8:981-6. doi: 10.2147/PPA.S53160. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 25045255 Free PMC article. Review.

6

Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemia.

Sweet K, Al Ali NH, Dalia SM, Komrokji RS, Crescentini RM, Tinsley S, Lancet JE, Papenhausen PR, Zhang L, Pinilla-Ibarz J. Sweet K, et al. Int J Hematol. 2014 Dec;100(6):567-74. doi: 10.1007/s12185-014-1685-9. Epub 2014 Oct 4. Int J Hematol. 2014. PMID: 25281405

7

Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned.

Pinilla-Ibarz J, Sweet KL, Corrales-Yepez GM, Komrokji RS. Pinilla-Ibarz J, et al. Among authors: sweet kl. Onco Targets Ther. 2016 Aug 10;9:4937-57. doi: 10.2147/OTT.S102504. eCollection 2016. Onco Targets Ther. 2016. PMID: 27570458 Free PMC article. Review.

8

Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.

Griffin PT, Komrokji RS, Sweet K, Al Ali NH, Padron E, Kubal TE, List AF, Lancet JE. Griffin PT, et al. Am J Hematol. 2017 Mar;92(3):232-237. doi: 10.1002/ajh.24627. Epub 2017 Feb 3. Am J Hematol. 2017. PMID: 28006850 Free article.

9

The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.

Kuykendall AT, Talati C, Al Ali N, Sweet K, Padron E, Sallman DA, Lancet JE, List AF, Zuckerman KS, Komrokji RS. Kuykendall AT, et al. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e45-e53. doi: 10.1016/j.clml.2017.08.002. Epub 2017 Aug 5. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28869184

10

A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.

Mirza AS, Lancet JE, Sweet K, Padron E, Pinilla-Ibarz J, Nardelli L, Cubitt C, List AF, Komrokji RS. Mirza AS, et al. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):902-907. doi: 10.1016/j.clml.2017.09.007. Epub 2017 Sep 19. Clin Lymphoma Myeloma Leuk. 2017. PMID: 29030092 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page